Mucormycosis is an ailment that originates from a saprophyte. Mucorales are a group of a growing number of members who have mucormycosis. The environmental contamination with fungal spore and now in COVID-19 the high use of steroid, which increases the occasion of mucor. It is a worldwide infectious disease as well as there is no vaccine to treat mucormycosis. Therapies for mucormycosis involve a coordinated surgical and medical approach. Antifungal therapy, iron sequestration, and adjunctive therapy are the various therapies to treat mucormycosis that will discuss in the article. Also the pathogenesis, identification of mucormycosis will review here.
Cite this article:
Devkar Aniket, Jadhav Sudha. Mucormycosis its Pathogenesis and Treatment. Research Journal of Science and Technology. 2021; 13(3):205-7. doi: 10.52711/2349-2988.2021.00031
Devkar Aniket, Jadhav Sudha. Mucormycosis its Pathogenesis and Treatment. Research Journal of Science and Technology. 2021; 13(3):205-7. doi: 10.52711/2349-2988.2021.00031 Available on: https://rjstonline.com/AbstractView.aspx?PID=2021-13-3-7
1. Sugar AM, Mucormycosis, Clinical Infectious Diseases, Volume 14, Issue Supplement_1, March 1992, Pages S126–S129
9. HOWARD DH. Classification of the Mucorales, pp. 93-4. In: LEHRER RI, moderator. Mucormycosis. Ann Intern Med. 1980;93 (Part 1):93-108
12. Ibrahim, A., Spellberg, B., & Edwards Jr, J. (2008). Iron Acquisition: a novel prospective on mucormycosis pathogenesis and treatment. Current opinion in infectious diseases, 21(6), 620.